Alzinova AB (ALZ)

Currency in SEK
1.33
+0.03(+2.47%)
Real-time Data·
ALZ Scorecard
Full Analysis
Net income is expected to grow this year
Earnings results expected in 14 days
ALZ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.301.37
52 wk Range
1.254.62
Key Statistics
Prev. Close
1.3
Open
1.31
Day's Range
1.3-1.37
52 wk Range
1.25-4.62
Volume
287.87K
Average Volume (3m)
704.84K
1-Year Change
-65.24%
Book Value / Share
1.32
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALZ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Alzinova AB Company Profile

Alzinova AB (publ), a clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden. Its lead product candidate is the ALZ-101, a therapeutic vaccine for the treatment of Alzheimer’s disease, which has completed phase 1b study. The company also develops ALZ-201, a monoclonal antibody that target and neutralize the neurotoxic forms of the peptide Aß42, called oligomers, which are considered to be the underlying cause of Alzheimer’s disease; and a humanized version of ALZ-201 in patients with Alzheimer’s disease that is in phase 1 clinical study. Alzinova AB (publ) was incorporated in 2011 and is based in Mölndal, Sweden.

Compare ALZ to Peers and Sector

Metrics to compare
ALZ
Peers
Sector
Relationship
P/E Ratio
−6.4x−9.6x−0.5x
PEG Ratio
−0.21−0.200.00
Price/Book
1.1x6.6x2.6x
Price / LTM Sales
6.8x42.3x3.3x
Upside (Analyst Target)
263.5%10.2%43.5%
Fair Value Upside
Unlock6.3%6.9%Unlock

Earnings

Latest Release
May 16, 2025
EPS / Forecast
-0.06 / --
Revenue / Forecast
6.09M / --
EPS Revisions
Last 90 days

ALZ Income Statement

People Also Watch

51.790
ASTS
-1.48%
1.900
OPEN
-24.60%

FAQ

What Stock Exchange Does Alzinova Trade On?

Alzinova is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Alzinova?

The stock symbol for Alzinova is "ALZ."

What Is the Alzinova Market Cap?

As of today, Alzinova market cap is 138.75M.

What Is Alzinova's Earnings Per Share (TTM)?

The Alzinova EPS (TTM) is -0.27.

When Is the Next Alzinova Earnings Date?

Alzinova will release its next earnings report on 20 Aug 2025.

From a Technical Analysis Perspective, Is ALZ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Alzinova Stock Split?

Alzinova has split 2 times.

How Many Employees Does Alzinova Have?

Alzinova has 5 employees.

What is the current trading status of Alzinova (ALZ)?

As of 07 Aug 2025, Alzinova (ALZ) is trading at a price of 1.33, with a previous close of 1.30. The stock has fluctuated within a day range of 1.30 to 1.37, while its 52-week range spans from 1.25 to 4.62.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.